Literature DB >> 11847592

Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.

Ryuji Kubota1, Samantha S Soldan, Roland Martin, Steven Jacobson.   

Abstract

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic inflammatory disease of the spinal cord in which HTLV-I Tax-specific cytotoxic T lymphocytes (CTL) have been suggested to be immunopathogenic. However, it is unknown whether the HTLV-I-specific CTL in the central nervous system differ from those in the periphery. We investigated functional T-cell receptor diversity in HTLV-I Tax11-19-specific CTL clones derived from peripheral blood and cerebrospinal fluid (CSF) of a HAM/TSP patient using analogue peptides of the viral antigen. CTL responses to the analogue peptides varied between T-cell clones, however, CTL clones from CSF showed limited recognition of the peptides when compared to those from peripheral blood. This suggests that CTL with highly focused specificity for HTLV-I Tax accumulate in the CSF and may contribute to the pathogenesis of HAM/TSP. Furthermore, this study provides a rationale for analogue peptide-based immunotherapeutic strategies focusing on the immunopathogenic T-cells in HTLV-I-associated neurologic disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847592     DOI: 10.1080/135502802317247811

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  20 in total

Review 1.  Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease.

Authors:  S Jacobson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

2.  Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

Authors:  M C Levin; T J Lehky; A N Flerlage; D Katz; D W Kingma; E S Jaffe; J D Heiss; N Patronas; H F McFarland; S Jacobson
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

3.  An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.

Authors:  R Kubota; S S Soldan; R Martin; S Jacobson
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

4.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

5.  Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells.

Authors:  M Osame; M Matsumoto; K Usuku; S Izumo; N Ijichi; H Amitani; M Tara; A Igata
Journal:  Ann Neurol       Date:  1987-02       Impact factor: 10.422

6.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

Authors:  U Utz; D Banks; S Jacobson; W E Biddison
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes.

Authors:  T Moritoyo; T A Reinhart; H Moritoyo; E Sato; S Izumo; M Osame; A T Haase
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

8.  Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.

Authors:  U Utz; J A Brooks; H F McFarland; R Martin; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.

Authors:  B D Evavold; P M Allen
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

Review 10.  Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.

Authors:  B Gran; B Hemmer; M Vergelli; H F McFarland; R Martin
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

View more
  17 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells.

Authors:  Julie M Johnson-Nauroth; Jerome Graber; Karen Yao; Steve Jacobson; Peter A Calabresi
Journal:  J Neuroimmunol       Date:  2006-06-05       Impact factor: 3.478

3.  HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.

Authors:  Rashida Ginwala; Breanna Caruso; Zafar K Khan; Ajinkya Pattekar; Glen M Chew; Michael J Corley; Ronak Loonawat; Steven Jacobson; Sreesha Sreedhar; Lishomwa C Ndhlovu; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-04       Impact factor: 4.147

4.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Authors:  Simona Ozden; Madeleine Cochet; Jacqueline Mikol; Antonio Teixeira; Antoine Gessain; Claudine Pique
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640

7.  Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.

Authors:  Masachika Senba; Kioko Kawai; Naoki Mori
Journal:  Leuk Res Treatment       Date:  2011-12-01

8.  A transgenic mouse model of human T cell leukemia virus type 1-associated diseases.

Authors:  Takeo Ohsugi
Journal:  Front Microbiol       Date:  2013-03-08       Impact factor: 5.640

Review 9.  Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.

Authors:  Kate Barmak; Edward W Harhaj; Brian Wigdahl
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 3.739

10.  HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.

Authors:  Nanae Yamamoto-Taguchi; Yorifumi Satou; Paola Miyazato; Koichi Ohshima; Masanori Nakagawa; Koko Katagiri; Tatsuo Kinashi; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.